Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT03889093
Eligibility Criteria:
Inclusion Criteria:
* Biopsy or image (in the setting of hepatocellular carcinoma (HCC)) diagnosed hepatic malignancy
* Total bilirubin \< 2 mg/dL
* ECOG status ≤ 2
* Life expectancy \>3 months as documented in the medical record by the enrolling physician
* Age \>22 years
* Lesion \>2.0 cm which is amenable to percutaneously biopsied
Exclusion Criteria:
* Unwilling or unable to attend all study related follow ups
* Technetium 99 macro aggregated albumin (MAA) lung shunt fraction \>20%
* Arterial anatomy which precludes the ability to safely perform RE
* INR \> 1.8 or platelet count \<50,000 which cannot be corrected
* Patients who are unable to hold anticoagulation and/or antiplatelet therapy in the periprocedural setting
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
22 Years
Study:
NCT03889093
Study Brief:
Protocol Section:
NCT03889093